Specifications
Immunogen
Recombinant protein
Applications
Application Notes
Suitable for use in sELISA.
We recommend the following as antibody pair (Capture - Detection):
CABT-L0749YC - CABT-L0750YD
Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
Target
Alternative Names
KDR; kinase insert domain receptor (a type III receptor tyrosine kinase); FLK1; CD309; VEGFR; VEGFR2; vascular endothelial growth factor receptor 2; soluble VEGFR2; fetal liver kinase 1; fetal liver kinase-1; protein-tyrosine kinase receptor Flk-1; tyrosine kinase growth factor receptor;
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody.
Learn More
Citations
Have you cited CABT-L0750YD in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Murohara, T; Ikeda, H; et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. JOURNAL OF CLINICAL INVESTIGATION 105:1527-1536(2000).
Yoshiji, H; Kuriyama, S; et al. Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. HEPATOLOGY 39:1517-1524(2004).
COA
Certificate of Analysis
![Human Anti-Human VEGFR2 (Ramucirumab) Monoclonal Antibody, clone Ramucirumab [Biosimilar] (CABT-Z696H)](https://img2.creative-diagnostics.com/productimage/CABT-Z696H_1.jpg)
